首页> 外文期刊>BMC Cancer >Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer
【24h】

Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer

机译:乳腺X线摄影密度和HER2过表达对浸润性乳腺癌患者诺丁汉预后指数的影响

获取原文
           

摘要

Background To investigate whether very low mammographic breast density (VLD), HER2, and hormone receptor status holds any prognostic significance within the different prognostic categories of the widely used Nottingham Prognostic Index (NPI). We also aimed to see whether these factors could be incorporated into the NPI in an effort to enhance its performance. Methods This study included 270 patients with newly diagnosed invasive breast cancer. Patients with mammographic breast density of Results Both mammographic breast density (VLD) ( p Conclusions Very low density (VLD) and HER2 positivity were prognostically significant factors independent of the NPI. Furthermore, the incorporation of VLD and HER2 to the NPI served to enhance its accuracy, thus offering a readily available and more accurate method for the evaluation of patient prognosis.
机译:背景为了研究在广泛使用的诺丁汉预后指数(NPI)的不同预后类别中,极低的乳腺钼靶密度(VLD),HER2和激素受体状态是否具有任何预后意义。我们还旨在查看是否可以将这些因素合并到NPI中以增强其性能。方法该研究纳入了270例新诊断为浸润性乳腺癌的患者。乳腺X线密度检查的患者结果乳腺X线密度(VLD)(p结论极低密度(VLD)和HER2阳性是独立于NPI的预后显着因素,此外,将VLD和HER2纳入NPI有助于增强其准确性,因此提供了一种容易获得且更准确的方法来评估患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号